Literature DB >> 2456021

Alzheimer's disease. A double-labeling immunohistochemical study of senile plaques.

D W Dickson1, J Farlo, P Davies, H Crystal, P Fuld, S H Yen.   

Abstract

The senile plaque is one of the histopathologic changes that characterizes Alzheimer's disease and the aging brain. The histopathology of senile plaques was studied using double-labeling immunohistochemistry and lectin histochemistry with thioflavin S fluorescent microscopy in 9 cases of Alzheimer's disease, 2 nondemented elderly individuals, and 3 individuals with non-Alzheimer primary degenerative dementias. Every plaque that was visualized with thioflavin also had amyloid, but not all thioflavin-positive plaques contained neurites that could be recognized with specific monoclonal antibodies to paired helical filament, tau, or neurofilament epitopes. Some neurofilament-positive neurites were not visualized with thioflavin, but almost all tau-positive neurites were colabeled with thioflavin. Microglia were associated with most plaques. Most plaques were also surrounded by fibrous astrocytes. These results suggest that amyloid may be the common feature that defines senile plaques, but that other elements may be more specific for Alzheimer's disease, because extensive neuritic degeneration was seen only in Alzheimer brains and not in either nondemented elderly individuals with senile plaques or in non-Alzheimer dementia cases.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2456021      PMCID: PMC1880629     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  49 in total

1.  The hippocampus: organizational patterns in health and senescence.

Authors:  A B Scheibel
Journal:  Mech Ageing Dev       Date:  1979-01       Impact factor: 5.432

2.  Observations on the brains of non-demented old people.

Authors:  B E Tomlinson; G Blessed; M Roth
Journal:  J Neurol Sci       Date:  1968 Sep-Oct       Impact factor: 3.181

Review 3.  Amyloid deposits and amyloidosis. The beta-fibrilloses (first of two parts).

Authors:  G G Glenner
Journal:  N Engl J Med       Date:  1980-06-05       Impact factor: 91.245

4.  Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein.

Authors:  G G Glenner; C W Wong
Journal:  Biochem Biophys Res Commun       Date:  1984-05-16       Impact factor: 3.575

5.  Neuritic (senile) plaques and filamentous changes in aged rhesus monkeys.

Authors:  H M Wiśniewski; B Ghetti; R D Terry
Journal:  J Neuropathol Exp Neurol       Date:  1973-10       Impact factor: 3.685

6.  The contribution of altered synapses in the senile plaque: an electron microscopic study in Alzheimer's dementia.

Authors:  N K Gonatas; W Anderson; I Evangelista
Journal:  J Neuropathol Exp Neurol       Date:  1967-01       Impact factor: 3.685

7.  Evidence for induction of localized amyloid deposits and neuritic plaques by an infectious agent.

Authors:  H M Wisniewski; R C Moretz; A S Lossinsky
Journal:  Ann Neurol       Date:  1981-12       Impact factor: 10.422

8.  Form and distribution of senile plaques seen in silver impregnated sections in the brains of intellectually normal elderly people and people with Alzheimer-type dementia.

Authors:  P H Gibson
Journal:  Neuropathol Appl Neurobiol       Date:  1983 Sep-Oct       Impact factor: 8.090

9.  Fibrous Astrocytes in senile dementia of the Alzheimer type.

Authors:  R Schechter; S H Yen; R D Terry
Journal:  J Neuropathol Exp Neurol       Date:  1981-03       Impact factor: 3.685

10.  Synaptic atrophy in the senescent hippocampus.

Authors:  W Bondareff
Journal:  Mech Ageing Dev       Date:  1979-01       Impact factor: 5.432

View more
  122 in total

1.  Microglia in Alzheimer's disease and transgenic models. How close the fit?

Authors:  D W Dickson
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

2.  Inhibition of NF-kappaB potentiates amyloid beta-mediated neuronal apoptosis.

Authors:  B Kaltschmidt; M Uherek; H Wellmann; B Volk; C Kaltschmidt
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

Review 3.  Targeting tau protein in Alzheimer's disease.

Authors:  Cheng-Xin Gong; Inge Grundke-Iqbal; Khalid Iqbal
Journal:  Drugs Aging       Date:  2010-05       Impact factor: 3.923

4.  Hematopoietic CC-chemokine receptor 2 (CCR2) competent cells are protective for the cognitive impairments and amyloid pathology in a transgenic mouse model of Alzheimer's disease.

Authors:  Gaëlle Naert; Serge Rivest
Journal:  Mol Med       Date:  2012-03-30       Impact factor: 6.354

5.  Alzheimer neuropathology in non-Down's syndrome mentally retarded adults.

Authors:  E R Popovitch; H M Wisniewski; M Barcikowska; W Silverman; C Bancher; E Sersen; G Y Wen
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

6.  Ultrastructure of the microglia that phagocytose amyloid and the microglia that produce beta-amyloid fibrils.

Authors:  J Frackowiak; H M Wisniewski; J Wegiel; G S Merz; K Iqbal; K C Wang
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

7.  Clearance of amyloid-β peptides by microglia and macrophages: the issue of what, when and where.

Authors:  Aaron Y Lai; Joanne McLaurin
Journal:  Future Neurol       Date:  2012-03-01

8.  The complex of microglial cells and amyloid star in three-dimensional reconstruction.

Authors:  J Wegiel; H M Wisniewski
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

9.  Curly fibers are tau-positive strands in the pre- and post-synaptic neurites, consisting of paired helical filaments: observations by the freeze-etch and replica method.

Authors:  K Ohtsubo; N Izumiyama; S Kuzuhara; H Mori; H Shimada
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

10.  Transgenic mice overexpressing reticulon 3 develop neuritic abnormalities.

Authors:  Xiangyou Hu; Qi Shi; Xiangdong Zhou; Wanxia He; Hong Yi; Xinghua Yin; Marla Gearing; Allan Levey; Riqiang Yan
Journal:  EMBO J       Date:  2007-05-03       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.